The Fragility Index for Assessing the Robustness of the Statistically Significant Results of Experimental Clinical Studies

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2021 Aug 6

PMID 34357573

Citations 13

Authors

Adrienne K Ho

Affiliations

Soon will be listed here.

Citing Articles

The Role of Double-Zero-Event Studies in Evidence Synthesis: Evaluating Robustness Using the Fragility Index.

Wang Z, Xing X, Mun E, Wu C, Lin L J Eval Clin Pract. 2025; 31(1):e14301.

PMID: 39780615 PMC: 11735258. DOI: 10.1111/jep.14301.

Fragility in cardiovascular randomized controlled trials with primary continuous outcomes (2018-2022) from multi-perspectives assessment: a cross-sectional survey.

Zhou X, Ruan W, Zhang G, Liu H, Wang T, Li J Ann Med. 2024; 56(1):2427909.

PMID: 39624960 PMC: 11616752. DOI: 10.1080/07853890.2024.2427909.

The Fragility of Statistically Significant Binary Outcomes for Treating Achilles Tendinopathy: A Systematic Review of Randomized Trials.

Anaspure O, Patel S, Baumann A, Newsom A, Anastasio A, Amendola A Foot Ankle Orthop. 2024; 9(4):24730114241300160.

PMID: 39575398 PMC: 11580056. DOI: 10.1177/24730114241300160.

Fragility analysis and systematic review of patellar resurfacing versus non-patellar resurfacing in total knee arthroplasty.

Polisetty T, Hohmann A, DiDomenico E, Lonner J J Exp Orthop. 2024; 11(3):e12113.

PMID: 39108460 PMC: 11301444. DOI: 10.1002/jeo2.12113.

Assessing robustness of results of randomised clinical trials using Fragility Index.

Nainar S Eur Arch Paediatr Dent. 2024; 25(5):777-778.

PMID: 39093533 DOI: 10.1007/s40368-024-00930-6.

References

Brown J, Lane A, Cooper C, Vassar M . The Results of Randomized Controlled Trials in Emergency Medicine Are Frequently Fragile. Ann Emerg Med. 2018; 73(6):565-576. DOI: 10.1016/j.annemergmed.2018.10.037. View

Narayan V, Gandhi S, Chrouser K, Evaniew N, Dahm P . The fragility of statistically significant findings from randomised controlled trials in the urological literature. BJU Int. 2018; 122(1):160-166. DOI: 10.1111/bju.14210. View

Evaniew N, Files C, Smith C, Bhandari M, Ghert M, Walsh M . The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey. Spine J. 2015; 15(10):2188-97. DOI: 10.1016/j.spinee.2015.06.004. View

Edwards E, Wayant C, Besas J, Chronister J, Vassar M . How Fragile Are Clinical Trial Outcomes That Support the CHEST Clinical Practice Guidelines for VTE?. Chest. 2018; 154(3):512-520. DOI: 10.1016/j.chest.2018.01.031. View

Noel C, McMullen C, Yao C, Monteiro E, Goldstein D, Eskander A . The fragility of statistically significant findings from randomized trials in head and neck surgery. Laryngoscope. 2018; 128(9):2094-2100. DOI: 10.1002/lary.27183. View

Ridgeon E, Young P, Bellomo R, Mucchetti M, Lembo R, Landoni G . The Fragility Index in Multicenter Randomized Controlled Critical Care Trials. Crit Care Med. 2016; 44(7):1278-84. DOI: 10.1097/CCM.0000000000001670. View

Bertaggia L, Baiardo Redaelli M, Lembo R, Sartini C, Cuffaro R, Corrao F . The Fragility Index in peri-operative randomised trials that reported significant mortality effects in adults. Anaesthesia. 2019; 74(8):1057-1060. DOI: 10.1111/anae.14656. View

Hacke C, Nunan D . Discrepancies in meta-analyses answering the same clinical question were hard to explain: a meta-epidemiological study. J Clin Epidemiol. 2019; 119:47-56. DOI: 10.1016/j.jclinepi.2019.11.015. View

Shen C, Shamsudeen I, Farrokhyar F, Sabri K . Fragility of Results in Ophthalmology Randomized Controlled Trials: A Systematic Review. Ophthalmology. 2017; 125(5):642-648. DOI: 10.1016/j.ophtha.2017.11.015. View

10.

. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581-7. DOI: 10.1056/NEJM199512143332401. View

11.

Condon T, Sexton R, Wells A, To M . The weakness of fragility index exposed in an analysis of the traumatic brain injury management guidelines: A meta-epidemiological and simulation study. PLoS One. 2020; 15(8):e0237879. PMC: 7433866. DOI: 10.1371/journal.pone.0237879. View

12.

Khan M, Ochani R, Shaikh A, Usman M, Yamani N, Khan S . Fragility Index in Cardiovascular Randomized Controlled Trials. Circ Cardiovasc Qual Outcomes. 2019; 12(12):e005755. PMC: 7962007. DOI: 10.1161/CIRCOUTCOMES.119.005755. View

13.

Atal I, Porcher R, Boutron I, Ravaud P . The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses. J Clin Epidemiol. 2019; 111:32-40. DOI: 10.1016/j.jclinepi.2019.03.012. View

14.

Chavalarias D, Wallach J, Li A, Ioannidis J . Evolution of Reporting P Values in the Biomedical Literature, 1990-2015. JAMA. 2016; 315(11):1141-8. DOI: 10.1001/jama.2016.1952. View

15.

Caldwell J, Youssefzadeh K, Limpisvasti O . A method for calculating the fragility index of continuous outcomes. J Clin Epidemiol. 2021; 136:20-25. DOI: 10.1016/j.jclinepi.2021.02.023. View

16.

Das S, Xaviar S . Calculation of the fragility index of randomized controlled trials in epilepsy published in twelve major journals. Epilepsy Res. 2019; 159:106258. DOI: 10.1016/j.eplepsyres.2019.106258. View

17.

Dawson J, Liu C, Francisco G, Cramer S, Wolf S, Dixit A . Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet. 2021; 397(10284):1545-1553. PMC: 8862193. DOI: 10.1016/S0140-6736(21)00475-X. View

18.

Scherer R, Meerpohl J, Pfeifer N, Schmucker C, Schwarzer G, von Elm E . Full publication of results initially presented in abstracts. Cochrane Database Syst Rev. 2018; 11:MR000005. PMC: 7073270. DOI: 10.1002/14651858.MR000005.pub4. View

19.

Woods K, Fletcher S, Roffe C, Haider Y . Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992; 339(8809):1553-8. DOI: 10.1016/0140-6736(92)91828-v. View

20.

Oviedo-Joekes E, Brissette S, Marsh D, Lauzon P, Guh D, Anis A . Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009; 361(8):777-86. PMC: 5127701. DOI: 10.1056/NEJMoa0810635. View